welcome
The Motley Fool

The Motley Fool

Business

Business & Economics

2 Beaten-Down Stocks to Avoid in the Tariff-Fueled Correction

The Motley Fool
Summary
Nutrition label

71% Informative

Some stocks are lagging the market for good reasons because their businesses look shaky.

These are the corporations to avoid even as they fall along with broader equities.

Teladoc Health might not feel a substantial direct impact from Trump 's tariffs.

Tandem Diabetes Care's prospects look bleak at the moment despite its highly innovative attributes.

The Motley Fool recommends DexCom and Medtronic and recommends the following options: long January 2026 $ 75 calls on DexCom , short January 2027 $ 65 calls on DexCom .

The Fool has also recommends Teladoc Health and DexCom as a better place to invest.

Small business owner?

Otherweb launches Autoblogger—a revolutionary way to bring more leads to any small business, using the power of AI.